MAPK9 and neoplasm: In addition, Beclin1 P54A-expressing and VHL-deficient 786-O and RCC4 cells exhibited no difference in tumor cell death (Fig. 5B), indicating that Beclin1 P54A suppresses glucose deprivation-induced cell apoptosis in a VHL-dependent manner.